Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children - An alternative to subcutaneous application when needed

Vnitrni Lekarstvi

Volumn 55, Issue 3, 2009, Pages 227-232

  Blatny J ^a   Fiamoli, V ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Antixa; Deep vein thrombosis; LMWH; Thrombosis

Indexed keywords

DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; BLEEDING; CHILD; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; PROPHYLAXIS; RECANALIZATION; RECOMMENDED DRUG DOSE; SCHOOL CHILD; SKIN BRUISING; THROMBOCYTOPATHY; TREATMENT DURATION; TREATMENT RESPONSE; VEIN OCCLUSION;

ADOLESCENT; ANTICOAGULANTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT; INFANT, NEWBORN; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; VENOUS THROMBOSIS;

EID: 63849269569     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hirsh J. Heparin. N Eng J Med 1991; 324: 1565-1574.
2. Collins R, Serimgeour A, Yusuf S ec al. Reduction in facal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedics and urologic surgery. N Eng J Med 1988; 318: 1162-1173.
3. Clagett GP, Reisch JS. Prevention in trombembolism in surgical patiens. Ann Surg 1988; 208: 227-240.
4. Castaman C, Roderghiero F, Dini E. Thrombotic complication during L-asparaginase treatement for acute lymfoblastic leukemia. Haematologica 1990; 75: 567-569.
5. Wise RC,Todd JK. Spontaneous lower-extremity venous thrombosis in children. Am J Dis Child 1973; 126: 766-769.
6. Bernstein D, Coupy S, Schouberg SK. Pulmonary embolism in adolescent. Am J Dis Child 1986; 140: 667-671.
7. Andrew M, David M, Adams M et al. Venous trombembolic (VTE) complication in children: first analyse of the Canadian registry of TVE. Blood 1994; 83: 1251-1257.
8. Schmidt B, Andrew M. Neonathal thrombosis: report of a prospectiv Canadian and Internetional registry. Paediatrics 1995; 96: 939-943.
9. Monagle P, Adams M, Mahoney M et al. Long-term outcome of pediatric thromboembolic disease: a repor from the Canadian Chilhood Thrombophilia registry. Pediatr Res 2000; 47: 763-766.
10. David M, Andrew M. Venous trombembolism complications in children: a critical review of the literature. J Pediatr 1993; 123: 337-346.
11. Andrew M, Monagle P, Brooker L. Thrombembolic complications during infancy and childhood. B. C. Decker, Hamilton, Ontario, Canada 2000.
12. Monagle P, Chalmers E, Chan A et al. Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence.Based Clinical Praktice Guidelines (8th ed). Chest 2008; 133: 887-968.
13. Massicotte P et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and Coumadin for the treatment of venous thrombembolic events in children: the RE- VIVE trial. Thromb Res 2003; 109: 85 92.
14. Hoffman U, Harenberg J, Bauer K et al. Bioequivalence of subcutaneous and intravenous body-weight-independent high-dose low- molecular-weight heparin Certoparin on anti-Xa, Geotest, and tissue factor pathway inhibitor activity in volunteers. Blood Coagulation and Fibrinolysis 2002; 13: 289-296.